Emerging and evolving concepts in cancer immunotherapy imaging

L Dercle, S Sun, RD Seban, A Mekki, R Sun, L Tselikas… - Radiology, 2023 - pubs.rsna.org
Criteria based on measurements of lesion diameter at CT have guided treatment with
historical therapies due to the strong association between tumor size and survival. Clinical …

[HTML][HTML] Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies

A Dimitrakopoulou-Strauss, L Pan… - European Journal of …, 2023 - Springer
Long axial field of view (LAFOV) PET-CT scanners have been recently developed and are
already in clinical use in few centers worldwide. Although still limited, the hitherto acquired …

[HTML][HTML] Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma

C Sachpekidis, L Pan, A Kopp-Schneider… - European Journal of …, 2023 - Springer
Aim The recent introduction of long axial field-of-view (LAFOV) PET/CT scanners has
yielded very promising results regarding image quality and sensitivity in oncological …

Dual-Targeting PET Tracers Enable Enzyme-Mediated Self-Assembly for the PET Imaging of Legumain Activity

C Lu, K Li, H Xi, D Hua, H Li, F Gao… - ACS Applied Materials …, 2023 - ACS Publications
Legumain, a lysosomal cysteine protease overexpressed in a variety of tumors, has been
considered a promising biomarker for various cancers. Precise detection of legumain activity …

[HTML][HTML] Joint EANM-SNMMI guideline on the role of 2-[18F] FDG PET/CT in no special type breast cancer

SC Vaz, JPP Woll, F Cardoso, D Groheux… - European Journal of …, 2024 - Springer
Purpose To provide an organized, international, state-of-the-art, and multidisciplinary
guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and …

[HTML][HTML] Tumor response assessment on imaging following immunotherapy

AM Berz, C Dromain, N Vietti-Violi, S Boughdad… - Frontiers in …, 2022 - frontiersin.org
In recent years, various systemic immunotherapies have been developed for cancer
treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints …

[HTML][HTML] Clinical application of immunoPET targeting checkpoint inhibitors

EM Abenavoli, F Linguanti, R Calabretta… - Cancers, 2023 - mdpi.com
Simple Summary Cancer treatment with immune checkpoint inhibitors (ICIs) has significantly
impacted patients' management and outcomes. To better assess the benefit of ICIs and …

[HTML][HTML] The role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and monitoring of large vessel vasculitides-a review article

M Bahrami, H Mohammadi… - American Journal of …, 2023 - ncbi.nlm.nih.gov
In the last two decades, advancements in positron emission tomography (PET) technology
have increased the diagnostic accuracy of patients with large-vessel vasculitis (LVV) …

Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop

LK Shankar, H Schöder, E Sharon, J Wolchok… - The Lancet …, 2023 - thelancet.com
As the immuno-oncology field continues the rapid growth witnessed over the past decade,
optimising patient outcomes requires an evolution in the current response-assessment …

[HTML][HTML] Beyond the Frontline: A Triple-Line Approach of Thoracic Surgeons in Lung Cancer Management—State of the Art

B Bottet, N Piton, J Selim, M Sarsam, F Guisier… - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is a heterogeneous disease, making it a complex and
challenging condition to diagnose and treat effectively. However, recent advances have …